Concepedia

David Bom

DB

Statistics

Publications

11

Citations

1.2K

H-Index

11

Active since

1997

Affiliations

University of Kentucky(Current)

Markey Cancer Center

University of Pittsburgh

Athersys (United States)

David Bom is an author at University of Kentucky specializing in pharmacology, medicinal chemistry, and chemotherapy.

Publications per year

1997–2012

11

Publications

11

Thermogravimetric Analysis of the Oxidation of Multiwalled Carbon Nanotubes:  Evidence for the Role of Defect Sites in Carbon Nanotube Chemistry

David Bom, Rodney Andrews, David A. Jacques et al. · Nano Letters · 2002 · 499 citations

, , +15

The Novel Silatecan 7-<i>tert</i>-Butyldimethylsilyl-10-hydroxycamptothecin Displays High Lipophilicity, Improved Human Blood Stability, and Potent Anticancer Activity

David Bom, Dennis P. Curran, Stefan Kruszewski et al. · Journal of Medicinal Chemistry · 2000 · 155 citations

, , +13

A General Synthetic Approach to the (20S)-Camptothecin Family of Antitumor Agents by a Regiocontrolled Cascade Radical Cyclization of Aryl Isonitriles

Hubert Josien, Sung‐Bo Ko, David Bom et al. · Chemistry - A European Journal · 1998 · 147 citations

, , +13

The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors

L. Nathan Tumey, David Bom, Bayard R. Huck et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 85 citations · Full text

, , +6

Novel A,B,E-Ring-Modified Camptothecins Displaying High Lipophilicity and Markedly Improved Human Blood Stabilities

David Bom, Dennis P. Curran, Ashok J. Chavan et al. · Journal of Medicinal Chemistry · 1999 · 74 citations

, , +6

1–5 of 11